Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection: Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load

Journal of Immunology

Volumn 156, Issue 7, 1996, Pages 2616-2623

  Harrer, Thomas ^a   Harrer, Ellen ^a   Kalams, Spyros A ^a   Barbosa, Peter ^b   Trocha, Alicja ^a   Johnson, R Paul ^a   Elbeik, Tarek ^b   Feinberg, Mark B ^b,c   Buchbinder, Susan P ^d   Walker, Bruce D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTES   (United States)

^d AIDS Office San Francisco   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA ANTIGEN CLASS 1;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CROSS REACTION; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MEMORY CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL; VIROGENESIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; CROSS REACTIONS; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; DNA, VIRAL; EPITOPE MAPPING; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS; VARIATION (GENETICS); VIREMIA;

EID: 0029880783     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. McMichael A. J., and B. D. Walker. 1994. Cytotoxic T lymphocyte epitopes: implications for HIV vaccines. AIDS 8(Suppl. 1):S155.
2. Koup R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650.
3. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103.
4. Carmichael A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249.
5. Klein M. R., and C. A. van Baalen. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1356.
6. Rinaldo C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, L. A., D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 -infected long-term nonprogressors. J. Virol. 69:5838.
7. Zinkernagel R. M., and H. Hengartner. 1994. T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS [Review]. Immunol. Today 15:262.
8. Phillips R. E., J. S. Rowland, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453.
9. Moskophidis D., and R. M. Zinkernagel. 1995. Immunobiology of CTL escape mutants of LCMV. J. Virol. 69:2187.
10. Nowak M., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koeppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
11. Harrer T., E. Harrer, S. A. Kalams, A. Trocha, R. P. Johnson, T. Elbeik, M. Feinberg, H. Cao, D. D. Ho, S. Buchbinder, and B. Walker. 1995. Strong cytotoxic T cells and weak neutralizing antibodies in long-term non-progressing HIV-1 infection. AIDS Res. Hum. Retroviruses. In press.
12. Walker B. D., C. Flexner, L. K. Birch, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514.
13. Johnson R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J. Immunol. 147:1512.
14. Johnson R. P., A. Trocha, T. M. Buchanan, and B. D. Walker. 1992. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
15. Johnson R. P., S. A. Hammond, A. Trocha, R. F. Siliciano, and B. D. Walker. 1994. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type I (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine. J. Virol. 68:3145.
16. Myers G., B. Korber, S. Wain-Hobson, R. F. Smith, and G. N. Pavlakis. 1993. A compilation and analysis of nucleic and amino acid sequences. In Human Retrovirses and AIDS. Los Alamos National Laboratory, Los Alamos, NM.
17. Walker B. D., C. Flexner, T. J. Paradis, T. C. Fuller, M. S. Hirsch, R. T. Schooley, and B. Moss. 1988. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64.
18. Kalams S. A., R. P. Johnson, A. K. Trocha, M. J. Dynan, H. S. Ngo, R. T. DAquila, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261.
19. Lubaki M. N., M. A. Egan, R. F. Siliciano, K. J. Weinhold, and R. C. Bollinger. 1994. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res. Hum. Retroviruses 10:1427.
20. Koup R. A., C. A. Pikora, K. Luzuriaga, D. B. Brettler, E. S. Day, G. P. Mazzara, and J. L. Sullivan. 1991. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J. Exp. Med. 174:1593.
21. Lefkovits I., and H. Waldmann. Limiting dilution analysis of cells of the immune system. Cambridge University Press, Cambridge, 1979.
22. Piatak M. J., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K. C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749.
23. + lymphocytes from HIV-1 infected persons in the presence of combination antiretroviral therapy. J. Infect. Dis. 172:88.
24. Bukrinsky M. I., S. Haggerty, M. P. Dempsy, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1993. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365:666.
25. Tsomides T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 (HIV-1). J. Exp. Med. 180:1283.
26. DiBrino M., K. C. Parker, J. Shiloach, M. Knierman, J. Lukszo, R. V. Turner, W. E. Biddison, and J. E. Coligan. 1993. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. Proc. Natl. Acad. Sci. USA 90:1508.
27. DiBrino M., K. C. Parker, D. H. Margulies, J. Shiolach, R. V. Turner, W. E. Biddeson, and J. E. Coligan. 1994. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. J. Biol. Chem. 269:32426.
28. Kalams S., R. P. Johnson, A. Trocha, K. Hartman, M. Dynan, T. Harrer, E. Harrer, S. Buchbinder, and B. D. Walker. 1996. T-cell receptor (TCR) usage and fine specificity of HIV-1-specific cytotoxic T lymphocyte (CTL) clones: analysis of quasispecies recognition revels a dominant response directed against a minor in vivo variant. J. Exp. Med. In press.
29. + T cells in the central region of the HIV-1 NEF protein. J. Immunol. 146:1560.
30. Falk K., O. Rotzschke, S. Stevanovic, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290.
31. Jassoy C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3313.
32. Hirsch M. S., and R. T. DAquila. 1993. Therapy for human immunodeficiency virus infection. N. Engl. J. Med. 328:1686.
33. + lymphocyte activity. J. Infect. Dis. 172:329.
34. Oehen S., H. Waldner, T. M. Kündig, H. Hengartner, and R. M. Zinkernagel. 1992. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. J. Exp. Med 176:1273.
35. Lau L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369:648.
36. Cao Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201.
37. Pantaleo G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein, C. Fox, L. K. Schrager, et al. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209.
38. Kirchhoff F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332:228.
39. + T-cell levels. AIDS 7:1159.